Transplant center characteristics associated with living-donor kidney transplantation: a cohort study with a hierarchical modeling approach.


Journal

Transplant international : official journal of the European Society for Organ Transplantation
ISSN: 1432-2277
Titre abrégé: Transpl Int
Pays: Switzerland
ID NLM: 8908516

Informations de publication

Date de publication:
Aug 2019
Historique:
received: 07 11 2018
revised: 07 01 2019
accepted: 19 03 2019
pubmed: 25 3 2019
medline: 23 2 2020
entrez: 24 3 2019
Statut: ppublish

Résumé

Transplant center organization, that is a modifiable factor, may affect the access to living-donor kidney transplantation (LDKT). The objective of this study was to identify the center characteristics associated with LDKT using a hierarchical analysis. This was a retrospective multicenter observational study of 8701 patients who received a first renal graft between 2010 and 2014 in 32 transplantation centers of France. Hierarchical modeling was used to estimate the center effect and organization associated with LDKT. Among 8507 patients, 1225 (12%) were transplanted with a LD kidney. There was a transplant center effect on the proportion of LDKT. After adjustment for patient and center characteristics, the random effect variance decreased by 47%. Patients transplanted at a center with more than four nephrologists [1.81 (95% CI: 1.10-2.95)] and more than 1.5 nurse transplant coordinators [1.98 (95% CI: 1.26-3.13)] were more likely to be transplanted with a LD kidney. ABO-incompatible program was associated with LDKT [2.23 (95% CI: 1.22-4.06)]. There was a transplant center effect on the proportion of LDKT that could be decreased by modifiable center characteristics. Our study suggests the importance of the transplant team organization on the LDKT utilization.

Identifiants

pubmed: 30903630
doi: 10.1111/tri.13429
doi:

Substances chimiques

ABO Blood-Group System 0

Types de publication

Journal Article Multicenter Study Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

865-875

Subventions

Organisme : Agence de la Biomédecine

Informations de copyright

© 2019 Steunstichting ESOT.

Auteurs

Valérie Châtelet (V)

Centre Universitaire des Maladies Rénales, CHU de Caen, Caen Cedex 9, France.

Philippe Gatault (P)

Service de Néphrologie et Immunologie Clinique, CHRU Bretonneau, Tours, France.

Marc Hazzan (M)

Service de Néphrologie - Transplantation, CHRU de Lille, Lille, France.

Dany Anglicheau (D)

Service de Néphrologie - Transplantation Adultes, Hôpital Universitaire Necker, Paris, France.

Guy Launoy (G)

U1086 Inserm, "ANTICIPE", Centre de Lutte Contre le Cancer François Baclesse, Caen Cedex 05, France.

Thierry Lobbedez (T)

Centre Universitaire des Maladies Rénales, CHU de Caen, Caen Cedex 9, France.

Bruno Moulin (B)

Service de Néphrologie et Transplantation, Hôpital Civil, Strasbourg, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH